Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
H. Lee Moffitt Cancer Center and Research Institute
NRG Oncology
Institut Cancerologie de l'Ouest
Pfizer
UNICANCER
Bristol-Myers Squibb
Brigham and Women's Hospital
M.D. Anderson Cancer Center
Emory University
Hoffmann-La Roche
M.D. Anderson Cancer Center
Neonc Technologies, Inc.
Sapience Therapeutics
Jonsson Comprehensive Cancer Center
Melanoma Institute Australia
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Melanoma Institute Australia
University of Utah
Yale University
Cancer Research UK
UNC Lineberger Comprehensive Cancer Center
Pfizer
Virginia Commonwealth University
Grupo Español Multidisciplinar de Melanoma
HUYABIO International, LLC.
SWOG Cancer Research Network
Stanford University
Washington University School of Medicine
Mayo Clinic
University of Southern California
Yale University
University of Southern California
Emory University
NRG Oncology
Grupo Español Multidisciplinar de Melanoma
Thomas Jefferson University
Columbia University
Tempus AI
Thomas Jefferson University
University of Florida
Inova Health Care Services
Cedars-Sinai Medical Center
Algemeen Ziekenhuis Maria Middelares
Taproot Health
ABM Therapeutics Corporation
National Cancer Institute (NCI)